Welcome.
Are you a healthcare professional?

This website contains promotional information for Chiesi's respiratory products, and is intended solely for UK healthcare professionals. Please confirm below, or go back to the home page.

UK-RES-2000248 Feb 2020

You are now leaving Chiesi's website

By clicking this link, you will be taken to a website that is not owned or controlled by Chiesi. Chiesi is not responsible for the content provided on that site.

Continue
Go back

UK-RES-2000003 Jan 2020

INTENDED FOR UK HEALTHCARE PROFESSIONALS
Background
Resources for HCPs

Key opinion leader videos

Chiesi Limited are pleased to make available the below resources for UK healthcare professionals.
Jane Scullion - Video play button
Jane Scullion
Respiratory Nurse Consultant
Fostair® (beclometasone/ formoterol): An expert opinion
Professor Dave Singh - Video play button
Professor Dave Singh
University of Manchester
Professor Dave Singh – The potential benefits of using a single inhaler to deliver triple therapy compared to separate inhalers

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Chiesi Limited on 0800 0092329 (UK) or PV.UK@Chiesi.com.

Professor Dave Singh | University of Manchester | Professor Dave Singh – The potential benefits of using a single inhaler to deliver triple therapy compared to separate inhalers

Jane Scullion | Respiratory Nurse Consultant | Fostair® (beclometasone/ formoterol): An expert opinion